(Q40555106)

21 September 2017

title

Involvement of GSK-3beta in TWEAK-mediated NF-kappaB activation (English)

1 reference

21 September 2017

0 references

Adelheid De Ketelaere

1

1 reference

21 September 2017

Linda Vermeulen

2

1 reference

21 September 2017

Jorge Vialard

3

1 reference

21 September 2017

Inez Van De Weyer

4

1 reference

21 September 2017

Jean Van Wauwe

5

1 reference

21 September 2017

Guy Haegeman

6

1 reference

21 September 2017

Inge Moelans

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

566

1 reference

21 September 2017

issue

1-3

1 reference

21 September 2017

page(s)

60-64

1 reference

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Ligand-receptor binding revealed by the TNF family member TALL-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Identification of a ligand for the death-domain-containing receptor Apo3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

TWEAK induces angiogenesis and proliferation of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

GSK3, a master switch regulating cell-fate specification and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

GSK-3: new thoughts on an old enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

Apoptosis induced by death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.04.041

10.1016/J.FEBSLET.2004.04.041

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference